Actinogen Medical Limited (ATGGF)

Actinogen Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 3, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	116	48	111	48	62	162
Market Cap Growth	122.92%	-56.84%	129.54%	-21.84%	-61.78%	854.59%
Enterprise Value	107	33	103	39	47	152
Last Close Price	0.04	0.02	0.01	0.01	0.02	0.02
PS Ratio	32.19	13.31	16.75	14.86	24.67	108.80
PB Ratio	9.64	3.99	8.45	5.42	4.13	12.37
P/TBV Ratio	10.68	4.41	9.45	6.61	4.72	14.97
EV/Sales Ratio	29.47	9.20	15.60	11.93	18.61	102.47
Debt / Equity Ratio	0.18	0.18	0.02	0.01	0.01	0.01
Asset Turnover	0.24	0.24	0.54	0.25	0.18	0.13
Quick Ratio	3.74	3.74	13.83	6.99	13.73	19.87
Current Ratio	3.76	3.76	13.91	7.04	13.80	19.99
Return on Equity (ROE)	-77.47%	-77.47%	-78.81%	-61.18%	-48.46%	-27.62%
Return on Assets (ROA)	-41.91%	-41.91%	-45.37%	-35.65%	-28.59%	-16.16%
Return on Capital (ROIC)	-46.12%	-46.12%	-49.45%	-38.79%	-30.09%	-16.91%
Return on Capital Employed (ROCE)	-82.90%	-82.90%	-66.40%	-81.90%	-43.70%	-22.20%
Earnings Yield	-8.34%	-20.16%	-7.84%	-14.80%	-10.58%	-1.81%
FCF Yield	-4.30%	-10.39%	-10.20%	-12.02%	-10.60%	-0.80%
Buyback Yield / Dilution	-37.04%	-37.04%	-20.69%	-4.92%	-22.20%	-25.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.